Eating Attitudes in Orthodontic Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-09

Study Completion Date

2023-09-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted on 70 individuals who presented to the Orthodontics Department of the Faculty of Dentistry at Necmettin Erbakan University. The Eating Attitudes Test (EAT-40) was administered to all patients at the beginning of their treatment (T1) and at the sixth month of treatment (T2), and they were asked to complete it.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Food Reward Circuit Change by Orthodontics

NCT05026411

Eating Disorders Eating Behavior Eating Habit +1 more

UNKNOWN NA

Impact of Clear Aligners and Metal Brackets on Nutritional Status

NCT05936463

Malocclusion

UNKNOWN

Vertical Gingival Display Changes Associated With Upper Premolars Extraction

NCT04375540

Gummy Smile Orthodontic Treatment

COMPLETED NA

Oral Hygiene Reminders in Orthodontic Patients

NCT04042389

Compliance, Treatment

COMPLETED NA

Comparison of the Clinical Efficacy of the Lingual Brackets and Labial Brackets in the Leveling Phase

NCT04357067

Irregular Teeth

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was conducted on 70 individuals who presented to the Orthodontics Department of the Faculty of Dentistry at Necmettin Erbakan University. Thirty-five patients were randomly selected to receive treatment with clear aligners, while the remaining 35 patients were treated with fixed orthodontic appliances. The Eating Attitudes Test (EAT-40) was administered at the beginning of treatment (T1) and at the sixth month of treatment (T2). Patients were asked to arrive at the clinic half an hour before their appointments to complete the questionnaire. The aim was to evaluate the effect of the type of orthodontic treatment on eating attitudes and behaviors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eating Behaviors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clear Aligner Treatment

Patients undergoing orthodontic treatment with clear aligners

Group Type EXPERIMENTAL

Orthodontic treatment

Intervention Type OTHER

Undergoing orthodontic treatment

Fixed Aligner Treatment

Patients undergoing orthodontic treatment with fixed appliance

Group Type EXPERIMENTAL

Orthodontic treatment

Intervention Type OTHER

Undergoing orthodontic treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Orthodontic treatment

Undergoing orthodontic treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. age ≥18 years,
2. dental Class I, II, or III malocclusion without skeletal discrepancy,
3. absence of impacted or missing teeth,
4. no history of orthodontic treatment,
5. indication for non-extraction orthodontic treatment,
6. Dental Aesthetic Index (DAI) score between 26 and 30,¹⁸
7. no systemic disease or related medication use